Ideglira improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin: Analyses of dual II and dual V

Authors
Category Primary study
JournalDiabetes
Year 2017
This article has no abstract
Epistemonikos ID: 525fd74af2259309a6345fa05f4359e3dbab83fc
First added on: Feb 08, 2025